Advance Notice: Briefs

DHHS issues updated monkeypox vaccine recommendation 

By: - August 15, 2022 7:32 am

Michigan Department of Health and Human Services | Susan J. Demas

Updated monkeypox (MPV) vaccine recommendations have been released by the Michigan Department of Health and Human Services (DHHS).

For more information, visit Michigan.gov/MPV.

Based on a recent announcement from the U.S. Food and Drug Administration (FDA), the agency’s Emergency Use Authorization (EUA) now permits providers to offer the JYNNEOS vaccine as an intradermal (between layers of the skin) injection, whereas previously it was only delivered subcutaneously (under the skin), including for those under 18. The change is expected to increase the number of doses up to five-fold. 

JYNNEOS is administered as two doses 28 days apart. DHHS says the intradermal route of administration has been shown to have the same immune response as the subcutaneous route. People are considered fully vaccinated approximately two weeks after their second dose of JYNNEOS.

“MPV continues to spread and we are hopeful that the increase in vaccination doses will help us prevent further spread and offer protection for those who may have been or may be exposed,” said DHHS’ chief medical executive, Dr. Natasha Bagdasarian. “We encourage those at risk to contact their local health department and get vaccinated as soon as possible.”

Because Michigan’s revised JYNNEOS strategy now encourages second doses to be administered per the recommended schedule, residents who have received a first dose should contact their local health department or provider for administration of a second dose 28 days after the first. DHHS says those who have received their first vaccination subcutaneously, may receive their second dose intradermally. If more than 28 days have passed since receiving the first dose, individuals should receive their second dose as soon as possible and do not have to restart the series. 

As intradermal and subcutaneous administrations have the equivalent immune response, providers are encouraged, where possible, to utilize intradermal injections so that the number of persons that can be vaccinated would be expanded.

Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our web site. Please see our republishing guidelines for use of photos and graphics.

Jon King
Jon King

Jon King has been a journalist for more than 35 years. He is the Past President of the Michigan Associated Press Media Editors Association and has been recognized for excellence numerous times, most recently in 2021 with the Best Investigative Story by the Michigan Association of Broadcasters. He is also an adjunct faculty member at Cleary University. Jon and his family live in Howell, where he also serves on the Board of Directors for the Livingston Diversity Council.

MORE FROM AUTHOR